The global drug screening market reached a value of US$ 5.42 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 9.36 Billion by 2027, exhibiting a CAGR of 9.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Drug screening includes analysis of blood, urine, hair, or saliva specimens using immunoassays (IAs) or gas chromatography (GC) with mass spectrometry (MS) to detect the presence of a drug in the body. It is utilized in various settings for different purposes, including clinical care, occupational health, legal prosecution, rehabilitation, and risk management. For instance, it is used in different medical settings to assist the triage of patients with altered mental status in rehabilitation. It also finds application in assessing abuse potential and adherence among patients that are receiving opioid therapy. Nowadays, several manufacturers are introducing devices that can auto verify results as per the patient’s electronic medical record in lesser time.
Drug Screening Market Trends:
Drug abuse can cause adverse safety and health impacts and lower the productivity and morale of employees. This, along with growing emphasis on creating a safe workplace, is positively influencing the use of drug screening in private companies to prevent employee substance abuse. In addition, governing agencies of various countries are mandating random drug screening for personnel law enforcement, military, national security, and public health. Furthermore, the rising number of fatal road accidents is catalyzing the demand for drug screening to maintain road safety worldwide. Apart from this, drug screening is used in sports and athletic competitions to detect performance-enhancing drugs, such as steroids and human growth hormone (HGH), in professional athletes. This, in confluence with the increasing participation of individuals in professional sports, is contributing to market growth. Moreover, substantial growth in pain management and opioid dependency clinics is anticipated to drive the demand for drug screening across the globe.
Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global drug screening market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and service, sample type and end user.
Breakup by Product and Service:
Equipment
Immunoassay Analyzers
Chromatography Instruments
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Assay Kits
Sample Collection Cups
Calibrators and Controls
Others
Laboratory Services
Breakup by Sample Type:
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others
Breakup by End User:
Hospitals
Drug Testing Laboratories
Workplaces
Drug Treatment Centers
Pain Management Centers
Personal Users
Criminal Justice System and Law Enforcement Agencies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global drug screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global drug screening market?
What are the key regional markets?
What is the breakup of the market based on the product and service?
What is the breakup of the market based on the sample type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global drug screening market and who are the key players?
What is the degree of competition in the industry?